Publications by authors named "Raymond Meyn"

Claim this Profile
T
Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints.
Jessica M Molkentine, David P Molkentine, Kathleen A Bridges, Tongxin Xie, Liangpeng Yang, Raymond E Meyn

Int J Radiat Biol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade.
David P Molkentine, Jessica M Molkentine, Kathleen A Bridges, David R Valdecanas, Annika Dhawan, Raymond E Meyn

Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer.
Xiyou Liu, Manish Kumar, Liangpeng Yang, David P Molkentine, David Valdecanas, Raymond E Meyn

Clin Cancer Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer.
Heath D Skinner, Uma Giri, Liang P Yang, Manish Kumar, Ying Liu, Raymond E Meyn

Clin Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic interrogation as a tool to optimize chemotherapeutic regimens.
Vlad C Sandulache, Yunyun Chen, Lei Feng, William N William, Heath D Skinner, Raymond E Meyn

Oncotarget· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.
Kathleen A Bridges, Xingxing Chen, Huifeng Liu, Crosby Rock, Thomas A Buchholz, Raymond E Meyn

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.
Heath D Skinner, Uma Giri, Liang Yang, Sang Hyeok Woo, Michael D Story, Raymond E Meyn

Clin Cancer Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everything Old Is New Again: Using Nelfinavir to Radiosensitize Rectal Cancer.
Raymond E Meyn, Sunil Krishnan, Heath D Skinner

Clin Cancer Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model.
Vlad C Sandulache, Yunyun Chen, Heath D Skinner, Tongtong Lu, Lei Feng, Raymond E Meyn

Mol Cancer Ther· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.
Abdullah A Osman, Marcus M Monroe, Marcus V Ortega Alves, Ameeta A Patel, Panagiotis Katsonis, Raymond E Meyn

Mol Cancer Ther· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
Uma Raju, David P Molkentine, David R Valdecanas, Amit Deorukhkar, Kathryn A Mason, Raymond E Meyn

Cancer Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.
Maria Angelica Cortez, David Valdecanas, Xiaochun Zhang, Yanai Zhan, Vikas Bhardwaj, Raymond E Meyn

Mol Ther· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells.
Kathleen A Bridges, Carlo Toniatti, Carolyn A Buser, Huifeng Liu, Thomas A Buchholz, Raymond E Meyn

Oncotarget· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib plus androgen deprivation and radiation therapy for patients with localized high-risk prostate cancer: results from a multi-institutional phase 1 study.
Paul G Corn, Danny Y Song, Elisabeth Heath, Jordan Maier, Raymond Meyn

Int J Radiat Oncol Biol Phys· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer.
Colin Brooks, Tommy Sheu, Kathleen Bridges, Kathy Mason, Deborah Kuban, Raymond Meyn

Radiat Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.
Heath D Skinner, Vlad C Sandulache, Thomas J Ow, Raymond E Meyn, John S Yordy

Clin Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.
Kathleen A Bridges, Hiroshi Hirai, Carolyn A Buser, Colin Brooks, Huifeng Liu, Raymond E Meyn

Clin Cancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress.
Adrienne N Howard, Kathleen A Bridges, Raymond E Meyn, Joya Chandra

Cancer Chemother Pharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor signaling as a regulatory mechanism of DNA repair.
Raymond E Meyn, Anapama Munshi, John V Haymach, Luka Milas, K Kian Ang

Radiother Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linking PTEN with genomic instability and DNA repair.
Raymond E Meyn

Cell Cycle· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of apoptosis in radiation oncology.
Raymond E Meyn, Luka Milas, K Kian Ang

Int J Radiat Biol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib radiosensitizes non-small cell lung cancer cells by suppressing cellular DNA repair capacity.
Toshimitsu Tanaka, Anupama Munshi, Colin Brooks, Jenny Liu, Marvette L Hobbs, Raymond E Meyn

Clin Cancer Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment.
Ann H Klopp, Erika L Spaeth, Jennifer L Dembinski, Wendy A Woodward, Anupama Munshi, Raymond E Meyn

Cancer Res· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells.
Nand K Sah, Anupama Munshi, Marvette Hobbs, Bing Z Carter, Michael Andreeff, Raymond E Meyn

Int J Radiat Oncol Biol Phys· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci.
Anupama Munshi, Toshimitsu Tanaka, Marvette L Hobbs, Susan L Tucker, Victoria M Richon, Raymond E Meyn

Mol Cancer Ther· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis